Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
CGI	GIB	5. nov 2024	112.79	+0.79
Chain Bridge Bancorp	CBNA	5. nov 2024	22.80	0.00
Chain Bridge I SPAC A	CBRG	5. nov 2024	11.39	0.00
Chain Bridge I Units	CBRGU	5. nov 2024	11.26	0.00
Champion Homes	SKY	5. nov 2024	91.51	+0.65
Champions Oncology	CSBR	5. nov 2024	4.09	-3.54
ChampionX	CHX	5. nov 2024	28.76	+1.16
Chanson International	CHSN	5. nov 2024	9.67	-10.46
ChargePoint	CHPT	5. nov 2024	1.39	+4.51
Charles & Colvard	CTHR	5. nov 2024	1.32	+9.09
Charles River Laboratories International	CRL	5. nov 2024	188.68	+3.40
Charles Schwab	SCHW	5. nov 2024	71.31	+0.49
Charlton Aria Acquisition Unit	CHARU	5. nov 2024	9.98	0.00
Chart Industries	GTLS-B	5. nov 2024	57.98	+3.98
Chart Industries	GTLS	5. nov 2024	149.07	+5.40
Charter Communications A	CHTR	5. nov 2024	382.38	+1.74
Chatham Lodging Trust (REIT) A Pref	CLDT-A	5. nov 2024	23.30	+0.13
Chatham Lodging Trust REIT	CLDT	5. nov 2024	7.90	+1.28
Cheche Group	CCG	5. nov 2024	0.86	+3.37
Check Point Software Technolgies	CHKP	5. nov 2024	171.04	+0.51
Check-Cap	CHEK	5. nov 2024	1.16	+1.33
Checkpoint Therapeutics	CKPT	5. nov 2024	3.30	-5.44
Cheer Holding	CHR	5. nov 2024	2.67	-4.30
Cheetah Mobile ADR	CMCM	5. nov 2024	4.44	-5.53
Cheetah Net Supply Chain Service	CTNT	5. nov 2024	2.58	+1.98
Chegg	CHGG	5. nov 2024	1.79	+7.19
Chemed	CHE	5. nov 2024	533.17	+1.55
Chemomab Therapeutics ADR	CMMB	5. nov 2024	1.44	-0.35
Chemours	CC	5. nov 2024	19.88	-3.40
Chemung Financial	CHMG	5. nov 2024	47.75	+0.97

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.